齐拉西酮肌内注射治疗急性精神分裂症患者的临床效果

Abstract
Figure/Table
References (16)
Related Citation (6)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical effect of Ziprasidone intramuscular injection in the treatment of acute schizophrenia.Methods A total of 120 patients with acute schizophrenia admitted to the Fourth People′s Hospital of Yingkou City from December 2017 to December 2019 were selected as the research subjects.According to the random number table method,they were divided into control group (60 cases) and research group (60 cases).The control group was treated with Haloperidol Injection,and the research group was treated with Ziprasidone Injection.The positive and negative symptom scale scores (PANSS),the total clinical effectiveness rate and the total incidence of clinical adverse reactions of the two groups before treatment and 72 hours after treatment were tested.Results The total score of PANSS,positive factor score,negative factor score and general psychopathological factor score of the two groups after treatment were lower than those before treatment,and the differences were statistically significant (P<0.05).The total score of PANSS,positive factor score,negative factor score and general psychopathological factor score before treatment between the two groups were compared,and the differences were not statistically significant (P>0.05).The total score of PANSS,positive factor score,negative factor score and the incidence of adverse reactions of the research group after treatment were all lower than those in the control group,and the differences were statistically significant (P<0.05).There was no statistical significance in the general psychopathological factor scores between the two groups after treatment (P>0.05).The total clinical effectiveness rate of the research group was higher than that in the control group,and the difference was statistically significant (P<0.05).Conclusion Ziprasidone Injection has obvious clinical efficacy and high safety in patients with acute schizophrenia.Compared with Haloperidol Injection,the incidence of adverse reactions is lower,which is worthy of clinical reference.

Key words： Ziprasidone Haloperidol Acute Schizophrenia Positive and negative symptom scale score

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Yu-hong

Cite this article:

CHEN Yu-hong. Clinical effect of Ziprasidone Intramuscular Injection in the treatment of acute schizophrenia[J]. 中国当代医药, 2021, 28(4): 63-65转69.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I4/63

[1]	陈涛，许锦泉，吴志雄，等.齐拉西酮和氟哌啶醇对首发精神分裂症患者的疗效及对认知功能和QTc 间期的影响[J].中国医学创新，2020，17（9）：137-140.
[2]	苏亮，徐逸，陆峥，等.齐拉西酮针剂治疗精神分裂症患者激越症状的Meta 回归[J].中山大学学报（医学版），2020，41（1）：118-126.
[3]	李和军，刘海军，刘忠.兴奋激越状态精神分裂症患者临床特点及齐拉西酮注射液序贯口服治疗的临床分析[J].湖南师范大学学报（医学版），2019，16（6）：141-143.
[4]	哈保卫，杨拥军.齐拉西酮联合氢溴酸西酞普兰治疗伴发抑郁症状精神分裂症临床效果分析[J].世界复合医学，2019，5（11）：1-3.
[5]	石善江.100例精神疾病患者CCMD-2-R 与ICD-10 诊断符合率对比分析[J].山东精神医学，2001，14（2）：128-129.
[6]	门涛.齐拉西酮注射液与氟哌啶醇注射液治疗老年精神分裂症急性激越症状的效果及安全性对比[J].中国当代医药，2019，26（1）：166-168，172.
[7]	许锦泉，陈涛，陈玲，等.齐拉西酮与氟哌啶醇注射液治疗女性首发精神分裂症患者激越症状的效果及安全性比较[J].广东医学，2018，39（13）：2058-2060.
[8]	常凤坤，王会娟.齐拉西酮针剂序贯口服胶囊治疗精神分裂症激越症的效果及安全性评价[J].临床医学工程，2018，25（6）：777-778.
[9]	刘莉莉，颜晨，孙学勇.齐拉西酮针剂与胶囊序贯治疗精神分裂症激越症状患者的疗效及对PANSS评分、SDSS评分和TESS评分的影响[J].中国现代药物应用，2018，12（10）：99-101.
[10]	廉鹏，孙梦梦，冯晓丽，等.齐拉西酮注射液联合治疗酒精所致震颤谵妄的临床研究[J].泰山医学院学报，2018，39（5）：519-521.
[11]	李辉.齐拉西酮注射液治疗首发精神分裂症急性激越临床疗效及安全性分析[J].中国处方药，2018，16（05）：55-56.
[12]	贾志伟，李伟华，王静.氟哌啶醇与国产齐拉西酮注射液治疗精神分裂症急性激越症状的效果观察[J].中国医药指南，2017，15（26）：52.
[13]	王韵，葛庆华，王慧芳，等.单次肌内注射用甲磺酸齐拉西酮在中国健康志愿者中的药动学研究[J].中国药学杂志，2017，52（9）：767-771.
[14]	贾峰，王立娜，王喆，等.精神分裂症兴奋激越患者从齐拉西酮注射剂转换为口服制剂的序贯治疗研究——一项1年的临床病例汇总分析[J].中国新药与临床杂志，2017，36（1）：45-49.
[15]	王建伟.甲磺酸齐拉西酮治疗精神分裂症急性激越症状的效果[J].中国继续医学教育，2017，9（7）：177-178.
[16]	张晓阳，杨晓江，王哲伟.齐拉西酮与氟哌啶醇注射液治疗精神分裂症急性激越症状的临床对照研究[J].四川精神卫生，2015，28（1）：42-44.